Articles published by Bayer

...

New Interim, Real-World Data Provides Additional Insights on Hyperkalemia and Safety of Kerendia® (finerenone) for Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

November 04, 2023

From Bayer

Via Business Wire

New Human Biomarker Findings Support Mechanism of Action of Kerendia® (finerenone) in Patients with Chronic Kidney Disease Associated with Type 2 Diabetes

November 02, 2023

From Bayer

Via Business Wire

Bayer and Broad Institute of MIT and Harvard Extend Research Collaboration to Develop New Cancer Therapies

November 02, 2023

From Bayer

Via Business Wire

FieldView and Combyne Platform Integration Helps Farmers Better Manage Grain Marketing and Build Profitability Insights

October 30, 2023

From Bayer

Via Business Wire

Bayer Unveils Latest Data from Oncology Portfolio at ESMO Congress 2023

October 12, 2023

From Bayer

Via Business Wire

Bayer and Dollar General Partner to Increase Access to Fruit and Veggies, Celebrate National School Lunch Week

October 11, 2023

From Bayer

Via Business Wire

Bayer to Partner With Twist Bioscience to Accelerate Drug Discovery

October 05, 2023

From Bayer

Via Business Wire

The Menopause Society Annual Meeting 2023: Bayer to present latest real-world evidence of menopausal symptoms and their treatment

September 27, 2023

From Bayer

Via Business Wire

Bayer’s Kerendia® (finerenone) Included in Latest Focused Guideline Clinical Updates from European Society of Cardiology

August 31, 2023

From Bayer

Via Business Wire

Bayer Expands Clinical Development Program Investigating Finerenone for Potential Treatment of Heart Failure

August 31, 2023

From Bayer

Via Business Wire

Bayer and Kroger Team to Help Improve Access to Health and Nutrition in Rural America

August 28, 2023

From Bayer

Via Business Wire

FieldView Rolls Out New Capabilities For Post-Harvest Analysis and Reporting

August 22, 2023

From Bayer

Via Business Wire

One in Four American Adults Would Rather Not Know They Have Cancer

August 21, 2023

From Bayer

Via Business Wire

Bayer Donates $500K to Support Maui Community After Devastating Fires

August 16, 2023

From Bayer

Via Business Wire

The Terror is Hatching: Bayer Unveils Upcoming “Rootworm Week”

August 03, 2023

From Bayer

Via Business Wire

Bayer Earns Top Score on 2023 Disability Equality Index

July 11, 2023

From Bayer

Via Business Wire

Bayer and Luke Bryan Reunite for Annual #HerestotheFarmer Campaign in Support of Feeding America and Rural Communities

June 28, 2023

From Bayer

Via Business Wire

Bayer initiates Phase III studies with investigational contrast agent gadoquatrane

June 27, 2023

From Bayer

Via Business Wire

FDA approves Bayer’s Ultravist® (iopromide) injection for contrast-enhanced mammography

June 23, 2023

From Bayer

Via Business Wire

Bayer to Investigate Finerenone in Phase III Study in Adults With Chronic Kidney Disease Associated With Type 1 Diabetes

June 22, 2023

From Bayer

Via Business Wire

Bayer Announces Senior Bayer Representative and President of Bayer U.S.

June 21, 2023

From Bayer

Via Business Wire

Bayer Announces Changes to U.S. Country Leadership Team

June 08, 2023

From Bayer

Via Business Wire

Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics

June 06, 2023

From Bayer

Via Business Wire

Latest Vitrakvi® (larotrectinib) Subgroup Analyses at ASCO 2023 Showcase Long-Term Efficacy and Safety Profile in Adult and Pediatric Patients with NTRK Gene Fusion Cancer, Across Solid Tumors

June 02, 2023

From Bayer

Via Business Wire

Bayer to acquire exclusive license from Cedilla Therapeutics on selective inhibitors in pre-clinical precision oncology

June 01, 2023

From Bayer

Via Business Wire

Bayer Launches Unit to Develop New Precision Health Consumer Products

May 31, 2023

From Bayer

Via Business Wire

Bayer Presents New Data Across Oncology Portfolio at the 2023 ASCO Annual Meeting

May 25, 2023

From Bayer

Via Business Wire

Bayer launches Seeing Red campaign around the treatment of Heavy Menstrual Bleeding (HMB)

May 16, 2023

From Bayer

Via Business Wire

Bayer Receives U.S. FDA Fast Track Designation for asundexian Atrial Fibrillation Program

May 16, 2023

From Bayer

Via Business Wire

Boundless Bio Announces $100 Million Oversubscribed Series C Financing co-led by Leaps by Bayer and RA Capital Management to Advance the First ecDNA-Directed Therapies (ecDTx) for Patients with Oncogene Amplified Cancer

May 16, 2023

From Bayer

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.